File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1440-1681.1996.tb03037.x
- Scopus: eid_2-s2.0-0029974157
- PMID: 8886509
- WOS: WOS:A1996VE53100031
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Endothelium-dependent responses and inhibition of angiotensin-converting enzyme
Title | Endothelium-dependent responses and inhibition of angiotensin-converting enzyme |
---|---|
Authors | |
Keywords | Angiotensin-converting enzyme Angiotensinconverting enzyme inhibitors Bradykinin Endothelium-dependent vasodilations Endothelium-derived hyperpolarizing factor Nitric oxide Prostacyclin |
Issue Date | 1996 |
Publisher | Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CEP |
Citation | Clinical And Experimental Pharmacology And Physiology, 1996, v. 23 n. 8, p. S23-S29 How to Cite? |
Abstract | 1. Experimental and clinical studies have demonstrated the efficacy of inhibitors of angiotensin-converting enzyme (ACE) in a variety of cardiovascular diseases. Both structural and functional improvements have been reported. 2. Hypertension, atherosclerosis, congestive heart failure or ageing are accompanied by endothelial dysfunctions. The vasoactive endothelium-derived relaxing factors, nitric oxide, endothelium-derived hyperpolarizing factor and prostacyclin, could be involved, depending on the pathology. 3. Some of the beneficial effects of ACE inhibitors may be due to the augmented release of these endothelial factors resulting from the protection of locally produced bradykinin, particularly at the endothelial level. |
Persistent Identifier | http://hdl.handle.net/10722/171183 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.610 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:12:34Z | - |
dc.date.available | 2012-10-30T06:12:34Z | - |
dc.date.issued | 1996 | en_US |
dc.identifier.citation | Clinical And Experimental Pharmacology And Physiology, 1996, v. 23 n. 8, p. S23-S29 | en_US |
dc.identifier.issn | 0305-1870 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171183 | - |
dc.description.abstract | 1. Experimental and clinical studies have demonstrated the efficacy of inhibitors of angiotensin-converting enzyme (ACE) in a variety of cardiovascular diseases. Both structural and functional improvements have been reported. 2. Hypertension, atherosclerosis, congestive heart failure or ageing are accompanied by endothelial dysfunctions. The vasoactive endothelium-derived relaxing factors, nitric oxide, endothelium-derived hyperpolarizing factor and prostacyclin, could be involved, depending on the pathology. 3. Some of the beneficial effects of ACE inhibitors may be due to the augmented release of these endothelial factors resulting from the protection of locally produced bradykinin, particularly at the endothelial level. | en_US |
dc.language | eng | en_US |
dc.publisher | Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CEP | en_US |
dc.relation.ispartof | Clinical and Experimental Pharmacology and Physiology | en_US |
dc.subject | Angiotensin-converting enzyme | - |
dc.subject | Angiotensinconverting enzyme inhibitors | - |
dc.subject | Bradykinin | - |
dc.subject | Endothelium-dependent vasodilations | - |
dc.subject | Endothelium-derived hyperpolarizing factor | - |
dc.subject | Nitric oxide | - |
dc.subject | Prostacyclin | - |
dc.subject.mesh | Aging | en_US |
dc.subject.mesh | Angiotensin-Converting Enzyme Inhibitors - Pharmacology | en_US |
dc.subject.mesh | Biological Factors - Pharmacology | en_US |
dc.subject.mesh | Cardiovascular Diseases - Drug Therapy - Physiopathology | en_US |
dc.subject.mesh | Endothelium - Physiopathology | en_US |
dc.subject.mesh | Epoprostenol - Pharmacology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Drug Effects | en_US |
dc.subject.mesh | Nitric Oxide - Pharmacology | en_US |
dc.title | Endothelium-dependent responses and inhibition of angiotensin-converting enzyme | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1111/j.1440-1681.1996.tb03037.x | - |
dc.identifier.pmid | 8886509 | - |
dc.identifier.scopus | eid_2-s2.0-0029974157 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0029974157&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 23 | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.spage | S23 | en_US |
dc.identifier.epage | S29 | en_US |
dc.identifier.isi | WOS:A1996VE53100031 | - |
dc.publisher.place | Australia | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0305-1870 | - |